LZIOX
Price
$20.80
Change
-$0.05 (-0.24%)
Updated
Sep 11 closing price
Net Assets
1.27B
VDVIX
Price
$18.10
Change
+$0.17 (+0.95%)
Updated
Sep 11 closing price
Net Assets
323.82B
Interact to see
Advertisement

LZIOX vs VDVIX

LZIOX vs VDVIX Comparison Chart in %
View a ticker or compare two or three
VS
LZIOX vs. VDVIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LZIOX is a StrongBuy and VDVIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VDVIX has more cash in the bank: 324B vs. LZIOX (1.27B). VDVIX pays higher dividends than LZIOX: VDVIX (2.37) vs LZIOX (1.72). LZIOX was incepted earlier than VDVIX: LZIOX (30 years) vs VDVIX (13 years). LZIOX (1.08) is less costly to investors than VDVIX (0.16). LZIOX is a more actively managed with annual turnover of: 45.00 vs. VDVIX (4.00). VDVIX has a lower initial minimum investment than LZIOX: VDVIX (0) vs LZIOX (2500). VDVIX annual gain was more profitable for investors over the last year : 21.95 vs. LZIOX (4.56). VDVIX return over 5 years is better than : 41.64 vs. LZIOX (8.23).
LZIOXVDVIXLZIOX / VDVIX
Total Expense Ratio1.080.16675%
Annual Report Gross Expense Ratio1.080.16675%
Fund Existence30 years13 years-
Gain YTD8.84416.72253%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B324B0%
Annual Yield % from dividends1.722.3773%
Returns for 1 year4.5621.9521%
Returns for 3 years39.9263.4863%
Returns for 5 years8.2341.6420%
Returns for 10 years45.15110.4241%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNEMX21.880.23
+1.06%
Dunham Emerging Markets Stock N
GSUKX25.800.26
+1.02%
Goldman Sachs International Eq Inc R6
TRPIX57.640.43
+0.75%
T. Rowe Price Value I
TSVAX23.330.13
+0.56%
PGIM Quant Solutions Small-Cap Val A
FRBRX212.75-0.45
-0.21%
Franklin Biotechnology Discovery R6